PharmiWeb.com - Global Pharma News & Resources
17-Jun-2020

curasan AG: Notification of a loss amounting to half of the equity capital in accordance with § 92 (1) AktG

curasan AG / Key word(s): Miscellaneous
curasan AG: Notification of a loss amounting to half of the equity capital in accordance with § 92 (1) AktG

17-Jun-2020 / 16:47 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.



curasan AG: Notification of a loss amounting to half of the equity capital in accordance with § 92 (1) AktG


Kleinostheim, Germany, 17 June 2020 - The Management Board of curasan AG (shares: ISIN DE000A2YPGM4 / convertible bond: ISIN DE000A2TR497) hereby announces that it must be assumed at its best judgment that a loss of more than half of the share capital has occurred. This loss is mainly due to operating losses, aggravated by the corona pandemic.

In principle, a loss of half of the equity capital triggers a statutory obligation under Section 92 (1) of the German Stock Corporation Act (AktG) to invite shareholders to a general meeting without delay. Insolvency proceedings were opened for the assets of curasan AG with the resolution of 01 June 2020, Az. 651 IN 63/20.Due to the current insolvency proceedings, there is no need for a general meeting to be convened as a matter of principle pursuant to Section 92 (1) of the German Stock Corporation Act, which is why the issuer refrains from convening such a meeting.

Several investors have submitted indicative takeover bids, which are currently being negotiated. The business operations of the Issuer will continue in full as before.

---- End of the ad hoc release ----


Contact curasan AG:
Andrea Weidner
Investor Relations &
Corporate Communications
+49 6027 40 900-51
ir@curasan.com


 

17-Jun-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: curasan AG
Lindigstraße 4
63801 Kleinostheim
Germany
Phone: 06027/40 900 0
Fax: 06027/40 900 29
E-mail: info@curasan.de
Internet: www.curasan.de
ISIN: DE000A2YPGM4
WKN: A2YPGM
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1072609

 
End of Announcement DGAP News Service

Editor Details

Last Updated: 17-Jun-2020